Annual Research Report 1 July 1973 -- 30 June 1974
Abstract
The objective of this research was to measure and determine the physiological and metabolic pathways of cyclotrimethylenetrinitramine (RDX) following oral, intraperitoneal and intravenous administration; its toxic and resultant pathological effects on the various organ systems; and the development of proper therapeutic and prophylactic procedures.Contents: Pathophysiological studies of potentially toxic substances; Biological effects of electromagnetic pulses; Suppression of secondary disease by in vitro exposure of mixtures of lymphoid and stem cells to purified antilymphocyte antibody; Endotoxin effects of mouse liver adenyl cyclase; Development of clinical approaches for the treatment of radiation sickness and graft versus host disease through management of the intestinal flora; Control of white cell population in the postirradiated animal; Glycoproteins in diabetes; Technetium-99m pyrophosphate--Comparison of ED50 for tetany and acidosis with acute LD50.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 30, 1974
- Accession Number
- ADA009327
Entities
People
- C. L. Cloud
- G. David Ledney
- M. P. Fink
- N. R. Schneider
- W. D. Skidmore
- W. J. Flor
Organizations
- Armed Forces Radiobiology Research Institute